Category Latin America/Caribbean

Promoting Caribbean Intellectual Property Law

Across the world, the Caribbean is renowned for its unique flavors in music and entertainment, its beaches, cricket, and its commonly acclaimed fun and sun. While these are well-deserved, and are sources of just pride, this common perception provides foliage which bars the examination and explanation of the real problems and needs in intellectual property in the Caribbean, writes attorney Abiola Inniss.

UN Project Examines Better Access To Drugs For The Poor Through Local Production

Improving access to medicines in developing countries through local pharmaceutical production is at the centre of a project involving several institutional actors working on health and trade. Technology transfer is key to local production, but some prerequisites like a favourable policy environment and the ability of developing countries to use technology transfer are essential to encourage local production, according to panellists at a recent event.

Fair Usage In Caribbean Intellectual Property

A panoramic view of the IP situation in the Caribbean would present to the observer a carnival of Olympic size replete with politicians, diplomats, rights advocates, consumer groups, law enforcement, and impotent jurists, all gyrating discordantly to the WIPO band while Caribbean citizens look on, or are pulled or shoved in, writes Abiola Inniss.

Caribbean IP: Ensure Unending Local Protection Of Traditional Knowledge

In the Caribbean, issues of traditional knowledge in intellectual property are hardly considered to be of special significance to the majority of policymakers and, except for a few pockets of interest groups such as a group of Rastafarians in Jamaica, the average citizen is uninformed on the subject. The protection of the cultural heritage of the region through a normative system of law is exceedingly necessary for the survival of our unique brand of cultural expression, writes Abiola Inniss.

Emerging Economies’ New Initiative On Falsified And Substandard Medicines

Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.